Birgitte Offersen

109 posts

Birgitte Offersen

@BOffersen

Professor, MD, chair of DBCG, breast cancer researcher, Aarhus University Hospital, Experimental Clinical Oncology, Danish Centre for Particle Therapy.

Aarhus, Danmark Bergabung Mayıs 2019

258 Mengikuti524 Pengikut

Tweet Disematkan

Birgitte Offersen@BOffersen·22 Tem

Together with my colleague we have recorded a session on target volume delineation in an early breast cancer patient. It’s a one hour session with tips and tricks, link below #estro #breastcancer 🤓👇 estro.org/ESTRO/media/ES…

English

Birgitte Offersen@BOffersen·18 Ara

Excellent. High-risk pts should be offered RNI incl IMN now. The analysis also shows gain from RNI in node-negative pts and that needs to be discussed. Looking forward🧐

Matthias Guckenberger@Mat_Guc

Virtual Grand Rounds in Radiation Oncology January 10th 17:00 - 17:30 CET Prof. Carolyn Taylor: Effect of regional lymph node radiotherapy. An EBCTCG meta-analysis of 14,324 women in 16 trials Link to Zoom Meeting 👇 usz.ch/veranstaltunge…

English

3.1K

Birgitte Offersen me-retweet

Ane Appelt@cancerphysicist·10 Eki

I am SO excited about this!!! 🤩 We've put together a brilliant (in my humble opinion😉) line-up of speakers to discuss the challenges facing clinical re-irradiation. Please join us, it's going to be so much fun! #ReIrradiation #medphys #radonc

ESTRO@ESTRO_RT

Join the Reirradiation Webinar Series. Our experts will unravel complexities of #reirradiation throughout 8 sessions, running from Oct 2023 to May 2024. 📅 Save the Date: 1st session kicks off on 26 Oct. It's FREE! 👉 Programme and Registration: bit.ly/3RZr2ci #RadOnc

English

13K

Birgitte Offersen@BOffersen·23 Eyl

@brunomeduri Interesting. Where can I find the quality assurance of the RT? Was level 1 fully irradiated in pts without surgery? Are we facing another Z0011 discussion about level 1 RT 🧐

English

906

Bruno Meduri@brunomeduri·22 Eyl

Sentinel Lymph Node Biopsy vs No Axillary Surgery: 5-year distant DFS 97.7% SLNB group vs 98.0% no surgery #SOUNDTrial jamanetwork.com/journals/jamao…

English

861

Birgitte Offersen@BOffersen·20 Ağu

@jfcdrr Probably 5 yr

English

JFC@jfcdrr·20 Ağu

@BOffersen Thrilled to see the trial results. Pls, what is the experted date for that?. Thanks

English

Birgitte Offersen@BOffersen·20 Ağu

Agree. RT is postponed for those who need it following a second breast conservation. Most likely a LR in these selected pts does not lead to distant failure. We have now randomised 600 pts in the DBCG Natural trial to +- partial breast RT. Heading for 926 pts🧐

Hope Rugo@hoperugo

Really important study!! We need to avoid over treatment when it doesn't help! @OncoAlert

English

1.8K

Birgitte Offersen@BOffersen·4 Tem

Helt enig👍. Lyder for godt til at være sandt, og jeg kan ikke finde Djævelen i detaljen…. Det ser ud til, at de mener det🤩🤓. Super måde at rekruttere, tillykke til dem, som får stillingerne🥂🧐

𝐌𝐀𝐑𝐈𝐀𝐍𝐍𝐄 𝐕𝐎𝐆𝐒𝐄𝐍@marianne_vogsen

Det her er altså en RIGTIG god ide @HerlevGentofte‼️ mindst 20% finansieret forskningstid, som led i hoveduddannelsesstilling 💪🏼en god mulighed for karriereudvikling for @YngreLaeger 👏🏼 #forskpol #uddpol #sundpol ➡️ sundhedsjobs.dk/jobopslag/4508…

Dansk

786

Birgitte Offersen@BOffersen·13 May

@christian_roenn @CaiGrau Indeed deserved🍾🇩🇰🤩

English

Chr Rønn Hansen@christian_roenn·12 May

My fantastic mentor and colleague @CaiGrau has been awarded the finest #ESTRO23 honor, through the Klaas Breur Award. I cannot think of a person that would deserve this more. #DAHANCA 🇩🇰💪

English

416

Birgitte Offersen@BOffersen·10 Mar

@j_grau_eriksen @EHNSnews Tillykke Jesper⭐️👍

Dansk

Birgitte Offersen@BOffersen·24 Şub

The figure on the cover is from the editorial—>use the ESTRO guidelines and report your results accordingly🧐. Lift the threshold for RT details when reporting RT from clinical studies: e.g. RT technique, target def., dose/fr, doses to OAR, etc

Radiotherapy & Oncology@RO_GreenJournal

Vol 179 - just published

English

2.7K

Birgitte Offersen@BOffersen·26 Oca

@rufusgifford Lovely true love ❤️. Fingers crossed for fast recovery🤞

English

213

Rufus Gifford@rufusgifford·25 Oca

A week ago I questioned whether I’d see this sight again. Stephen came home ❤️❤️‍🩹 Many of you have asked how all this happened. Here goes:

English

107

3.9K

582.1K

Birgitte Offersen@BOffersen·23 Ara

Link to article: pubmed.ncbi.nlm.nih.gov/36265685/

English

434

Birgitte Offersen@BOffersen·23 Ara

Radiation associated induration is closely related to irradiated breast volume in the DBCG PBI trial. Validation in the DBCG Hypo trial showed surprising and interesting findings. More info at ESTRO2023 @ESTRO_RT @RadiotherapyOn1

English

6.3K

Birgitte Offersen@BOffersen·21 Ara

@merino_tomas Proton is a meeting the day before BIGART. The BIGART is mostly biology, imaging and translational research in photons

English

Tomas Merino@merino_tomas·21 Ara

@BOffersen Nice to read about this. Is this a Proton-physics Biology conference or all radiation biology? Just asking. Thanks

English

135

Birgitte Offersen@BOffersen·20 Ara

BIGART is truly a great conference🧐. I am looking forward to the meeting⭐️

English

1.2K

Birgitte Offersen@BOffersen·13 Ara

@DCCC_RT @acrobatic_dk Super godt at vi sammen forhåbentlig kan give længere progressionsfri overlevelse til vores patienter samtidig med relativ skånsom behandling 👍

Dansk

Birgitte Offersen@BOffersen·9 Eyl

Congratulations to Michael. What an honour to have several doctor titles 🥂🤓⭐️🇩🇰

Jens Overgaard@profOvergaard

A good day for radiation oncology and Aarhus University Professor Michael Baumann DKFZ recieve a honorary doctorate: dr.med honoris causa Congratulations

English

Birgitte Offersen@BOffersen·8 Ağu

@jeris_123 Since 2018 all Danish PBI candidates age minimum 60yr are offered randomisation in the DBCG RT Natural trial, which is 40Gy/15fr PBI versus no RT. Thus, we use 15 fr as SOC. You are invited to participate👍

English

IvanT@jeris_123·8 Ağu

@BOffersen Congrats! Would u then by extrapolation recommend 26Gy/5 PBI for this cohort?

English

Birgitte Offersen@BOffersen·7 Ağu

The first results from the DBCG PBI trial support standard use of external beam PBI 40Gy/15fr for selected breast cancer pts. Less morbidity and very few cancer events (not related to PBI). PBI has been DBCG standard since 2016 for low risk BC pts. Graphs & link below 👇

English